What's new? Log in Free sign up

Hypha Labs (FUNI)

Company Profile

Company profile

Ticker

FUNI

Exchange

Website

CEO

Mr. A. Stone Douglass

Incorporated

Location

Fiscal year end

Industry (SIC)

Services - Testing Laboratories

UL Solutions • NeoGenomics • Applied DNA Sciences • 20/20 GeneSystems ...

Former names

Digipath, Inc., DigiPath,Inc.

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

FUNI stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

Information statement

Entry into a Material Definitive Agreement

Preliminary information

Quarterly report

14 Aug 24

Quarterly report

20 May 24

Amendments to Articles of Incorporation or Bylaws

Departure of Directors or Certain Officers

Completion of Acquisition or Disposition of Assets

Quarterly report

14 Feb 24

Annual report (amended)

18 Jan 24

Latest ownership filings

View all

A STONE DOUGLASS

A STONE DOUGLASS

A STONE DOUGLASS

Dennis Hartmann

Todd A Peterson

Financial summary

Financial statements Chart FUNI financial data

Quarter (USD)	Jun 24	Mar 24	Dec 23	Sep 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Sep 23	Sep 22	Sep 21	Sep 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Hypha Labs earnings reports.

Institutional ownership, Q3 2019

FUNI institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	0	1	EXIT
Opened positions	0	0
Closed positions	1	0	NEW
Increased positions	0	0
Reduced positions	0	1	EXIT

13F shares	Current	Prev Q	Change
Total value	0.00	16.00 k	EXIT
Total shares	0.00	124.68 k	EXIT
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change

Largest transactions	Shares	Bought/sold	Change
Panagora Asset Management	0.00	-124.68 k	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Press releases

From Benzinga Pro

Hypha Laboratories Announces Completion of Phase 1 of Its State-of-the-Art Facility and Arrival of V5 Working MicroPearls(TM) Prototypes

Advancements Enhance Efficacy in Hypha's Revolutionary Home and Commercial Production UnitsLAS VEGAS, NV / ACCESSWIRE / November 18, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the

Emerging Markets Report: A Mushroom Monster in the Making

An Emerging Markets Sponsored Commentary ORLANDO, Fla., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Today's featured profile ticks all the boxes for us when we are looking at a potential investment . It is a potential monster

Hypha Laboratories Establishes Scientific and Cultural Advisory Board, Adds William Padilla-Brown

Board Will Add to Company's Intellectual Capital and Diversity of ExperienceLAS VEGAS, NV / ACCESSWIRE / October 15, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the

Hypha Laboratories Reveals New Patent Applications for Novel A.I. Driven In-Home Mycelium Production

Hypha Labs, Inc. Reveals First Functional Mushroom Ingredient Array for Home and Commercial Production

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.